Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
Maureen Sampson, Clarence Ling, Qian Sun, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 5, pp. 540-540
Open Access | Times Cited: 381

Showing 1-25 of 381 citing articles:

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4264
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg, Chris J. Packard, M. John Chapman, et al.
European Heart Journal (2021) Vol. 42, Iss. 47, pp. 4791-4806
Open Access | Times Cited: 529
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Journal of Preventive Cardiology (2021) Vol. 29, Iss. 1, pp. 5-115
Open Access | Times Cited: 376
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
Donald M. Lloyd‐Jones, Pamela B. Morris, Christie M. Ballantyne, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 14, pp. 1366-1418
Open Access | Times Cited: 290
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
Salim S. Virani, Pamela B. Morris, Anandita Agarwala, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 9, pp. 960-993
Open Access | Times Cited: 208
Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study
Benjamin Nilsson Wadström, Anders Berg Wulff, Kasper Mønsted Pedersen, et al.
European Heart Journal (2021) Vol. 43, Iss. 34, pp. 3258-3269
Closed Access | Times Cited: 150
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 6, pp. 1447-1547
Open Access | Times Cited: 132
Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, et al.
European Heart Journal (2023) Vol. 44, Iss. 16, pp. 1432-1445
Closed Access | Times Cited: 97
World Heart Federation Cholesterol Roadmap 2022
Kausik K. Ray, Brian A. Ference, T. Séverin, et al.
Global Heart (2022) Vol. 17, Iss. 1, pp. 75-75
Open Access | Times Cited: 89
Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction
Takahito Doi, Anne Langsted, Børge G. Nordestgaard
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 24, pp. 2383-2397
Open Access | Times Cited: 81
2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines
О. М. Драпкина, А. V. Kontsevaya, А. М. Калинина, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2022) Vol. 21, Iss. 4, pp. 3235-3235
Open Access | Times Cited: 80
Dyslipidemia
Marios Arvanitis, Charles J. Lowenstein
Annals of Internal Medicine (2023) Vol. 176, Iss. 6, pp. ITC81-ITC96
Closed Access | Times Cited: 65
Depression and cognition are associated with lipid dysregulation in both a multigenerational study of depression and the National Health and Nutrition Examination Survey
Seema Mehdi, Ana Paula Costa, Connie Svob, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Modification of lipoprotein metabolism and function driving atherogenesis in diabetes
Lorenzo Luciani, Matteo Pedrelli, Paolo Parini
Atherosclerosis (2024) Vol. 394, pp. 117545-117545
Open Access | Times Cited: 16
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study
Jessica R. Schubert, Bertil Lindahl, Håkan Melhus, et al.
European Heart Journal (2020) Vol. 42, Iss. 3, pp. 243-252
Open Access | Times Cited: 131
Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline
Connie B. Newman, Michael J. Blaha, Jeffrey B. Boord, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 12, pp. 3613-3682
Open Access | Times Cited: 104
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group
Peter W.F. Wilson, Terry A. Jacobson, Seth S. Martin, et al.
Journal of clinical lipidology (2021) Vol. 15, Iss. 5, pp. 629-648
Open Access | Times Cited: 93
Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
Chris J. Packard, M. John Chapman, M Sibartie, et al.
Heart (2021) Vol. 107, Iss. 17, pp. 1369-1375
Open Access | Times Cited: 83
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test
Maureen Sampson, Anna Wolska, Russell Warnick, et al.
Clinical Chemistry (2021) Vol. 67, Iss. 7, pp. 987-997
Open Access | Times Cited: 68
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels
Aparna Sajja, Jihwan Park, Vasanth Sathiyakumar, et al.
JAMA Network Open (2021) Vol. 4, Iss. 10, pp. e2128817-e2128817
Open Access | Times Cited: 68
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 5, pp. 429.e1-429.e104
Closed Access | Times Cited: 47
Food Insecurity Among Individuals With Cardiovascular Disease and Cardiometabolic Risk Factors Across Race and Ethnicity in 1999-2018
Eric Brandt, Tammy Chang, Cindy W. Leung, et al.
JAMA Cardiology (2022) Vol. 7, Iss. 12, pp. 1218-1218
Open Access | Times Cited: 43
Best practice for LDL-cholesterol: when and how to calculate
Janine Martins, Nicolene Steyn, H. Muller Rossouw, et al.
Journal of Clinical Pathology (2023) Vol. 76, Iss. 3, pp. 145-152
Closed Access | Times Cited: 33
Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 5, pp. 1144-1155
Closed Access | Times Cited: 10
Associations of per- and polyfluoroalkyl substances with maternal metabolic and inflammatory biomarkers in early-to-mid-pregnancy
Maria E Cinzori, Diana C. Pacyga, Libeth Rosas, et al.
Environmental Research (2024) Vol. 250, pp. 118434-118434
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top